After Hours Summary: GTLB +12.4 up big on earnings; ZS -12.8%, ASAN -12.7%, and PD -12.4% among laggards following quarterly results; NVDA -2.3% down on DOJ subpoena, according to Bloomberg
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: GTLB +12.4%, OS +0.7%, HLX +0.1% (guidance)
Companies trading higher in after hours in reaction to news: CLOV +20% (subsidiary signs agreement with The Iowa Clinic, P.C. to deploy AI tech), AURA +7.2% (to host urologic oncology investor event), CLLS +3.5% (presents pre-clinical evidence), RNG +2% (CFO resigns), RYAM +1.3% (increasing prices for Cellulose Specialties products), AMD +0.7% (former VP of AI initiatives at NVDA joining company), BTSG +0.5% (to acquire Haven Hospice for $60 mln), CRM +0.1% (to acquire Tenyx), CW +0.1% (awarded $26 mln Belgian Air Force contract)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: ASND -19.1% (enters into $150 mln funding agreement with Royalty Pharma), ZS -12.8%, ASAN -12.7% (also names new CFO), PD -12.4%, HQY -2.7% (also authorizes up to $300 mln for repurchases), GPK -1.1% (guidance)
Companies trading lower in after hours in reaction to news: ATHA -75.3% (topline results from Phase 2/3 LIFT-AD clinical trial of fosgonimeton), ULS -4.8% (stock offering), IRT -4.3% (stock offering), PACS -3.5% (stock offering), STWD -3.1% (stock offering), MGX -2.4% (preclinincal data for Lead Hemophilia A Program), NVDA -2.3% (receives DOJ subpoena, according to Bloomberg), STC -1.9% (increases dividend), CIFR -1.6% (files mixed shelf), AKBA -1.4% ($250 mln mixed shelf offering), PCVX -1.2% ($1.0 bln stock offering and pre-funded warrants), ARCB -1.2% (provides prelim August metrics), NOC -0.1% (awarded U.S. Navy contract), PFE -0.1% (Acepodia enters strategic clinical collaboration with Pfizer)